TAFAMIDIS

Course overview

TAFAMIDIS IS AN ORAL MEDICATION FOR TREATING CARDIOMYOPATHY AND PERIPHERAL NEUROPATHY DUE TO TRANSTHYRETIN AMYLOIDOSIS (ATTR). IT IS A TRANSTHYRETIN STABILIZER AND HAS BEEN SHOWN TO REDUCE DISEASE PROGRESSION AND MORTALITY SIGNIFICANTLY. THIS ACTIVITY WILL HIGHLIGHT THE CURRENT INDICATIONS, MECHANISM OF ACTION, DOSAGE, AND CONTRAINDICATIONS OF TAFAMIDIS IN A CLINICAL SETTING PERTINENT FOR HEALTHCARE TEAM MEMBERS.